Skip to main content
NCBI home page
Viral Immunology logoLink to Viral Immunology
. 2014 Aug 1;27(6):305–315. doi: 10.1089/vim.2013.0113

Allo-Antigen Stimulated CD8+ T-Cells Suppress NF-κB and Ets-1 DNA Binding Activity, and Inhibit Phosphorylated NF-κB p65 Nuclear Localization in CD4+ T-cells

Ryuichi Nagashima 1, Fumitaka Kawakami 2, Shinichiro Takahashi 3, Fumiya Obata 1,,4, Makoto Kubo 1,,4,✉
PMCID: PMC4076998  PMID: 24844121

Abstract

CD8+ T-cells of asymptomatic HIV-1 carriers (AC) suppress human immunodeficiency virus type 1 (HIV-1) replication in a class I major histocompatibility complex (MHC-I)-restricted and -unrestricted manner. In order to investigate the mechanism of MHC-I-unrestricted CD8+ T-cell-mediated HIV-1 suppression, we previously established allo-antigen stimulated CD8+T-cells from HIV-1-uninfected donors. These allo-antigen stimulated CD8+ T-cells suppressed HIV-1 replication in acutely infected autologous CD4+ T-cells when directly co-cultured. To elucidate the mechanism of HIV-1 replication suppression, we analyzed DNA-binding activity and phosphorylation of transcriptional factors associated with HIV-1 replication by electrophoresis mobility shift assay and Western blotting. When CD4+ T-cells were cultured with allo-antigen stimulated CD8+ T-cells, the reduction of NF-κB and Ets-1 DNA-binding activity was observed. Nuclear localization of NF-κB p65 and Ets-1 was suppressed in CD4+ T-cells. Although NF-κB p65 and Ets-1 are known to be regulated by protein kinase A (PKA), no difference was observed in the expression and phosphorylation of the PKA catalytic subunit in CD4+ T-cells cultured with PHA-treated CD8+ T-cells or allo-antigen stimulated CD8+ T-cells. Cyclic AMP is also known to enter through gap junctions, but the suppression of HIV-1 replication mediated by allo-antigen stimulated CD8+ T-cells was not affected by the gap junction inhibitor. The nuclear transport of phosphorylated NF-κB p65 (Ser276) was inhibited only in CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells. Our results indicate that allo-antigen stimulated CD8+ T-cells suppress the transcriptional activity of NF-κB p65 or Ets-1 in an antigen-nonspecific manner, and inhibit the nuclear transport of phosphorylated NF-κB p65 (Ser276).

Introduction

Human immunodeficiency virus type 1 (HIV-1) is a lentivirus responsible for the development of acquired immunodeficiency syndrome (AIDS). HIV-1 infection stimulates strong immune responses, and CD8+ T-cells including HIV-1-specific cytotoxic T lymphocytes (CTLs) play important roles in controlling viral replication in HIV-1-infected individuals (4,10,25,44). Previous studies have shown that CD8+ T-cells of asymptomatic HIV-1 carriers (AC) suppress HIV-1 replication in autologous peripheral blood mononuclear cells (PBMC) (3,13,45). HIV-1-specific CD8+ CTLs lyse major histocompatibility complex-I (MHC-I)-matched B cells expressing HIV-1 antigens (15,33,43). The clinical significance of these CD8+ T-cells has been supported by studies using a simian immunodeficiency virus (SIV)-infected simian AIDS model system both ex vivo and in vivo (12,13). These have demonstrated that reduction of viremia in the acute phase of SIV infection is associated with the appearance of SIV-specific CTLs, and that depletion of CD8+ T-cells from monkeys persistently infected with SIV causes an increase of viral load in vivo (34). These findings imply that CD8+ T-cells are common mediators contributing to both recovery from the acute phase and maintenance of an asymptomatic state in these virus infections.

It is well known that the antiviral activities of AC-CD8+ T-cells involve both MHC-I-restricted and -unrestricted suppression (29). Previous studies have revealed that HIV-1-infected cells may be resistant to HIV-1-specific CTL-mediated cytotoxicity because of down-modulation of MHC-I by HIV-1 Nef (7). CTL activity against HIV-1-infected CD4+ T-cells may not be the only mechanism of CD8+ T-cell-mediated suppression. CD8+ T-cells produce many soluble factors that can suppress HIV-1 replication in vitro, including macrophage inflammatory protein 1-α (MIP-1α), MIP-1β, regulated on activation normal T-cell expressed and secreted (RANTES), stromal cell-derived factor 1, macrophage-derived chemokine (MDC), interleukin-16, interferons, and defensin (1,6,27,30,48,50). However, neutralizing antibodies against these cytokines or chemokines only partially inhibit the suppressive activity of CD8+ T-cells of AC (3,5,28). Levy et al. reported that CD8+ T-cell antiviral factor (CAF) can suppress HIV-1 replication at the transcriptional level without causing cell killing (22). However, the molecular aspects of CAF remain unclear. Furthermore, Liu et al. reported that HIV-1-irrelevant CD8+ CTLs established from HIV-1-uninfected donors also inhibit X4 and R5 HIV-1 replication in a cell-contact manner (21). These CTLs partially kill HIV-1-infected PBMC via the Fas ligand, but CTLs are able to suppress HIV-1 replication at a late stage in the presence of neutralizing antibodies against Fas ligand. The precise mechanisms of HIV-1 suppression by CD8+ CTLs are not fully understood. HIV-1 suppression may occur through regulation of transcriptional factors in CD4+ T-cells co-cultured with HIV-1-irrelevant CD8+ CTLs.

Previous papers have reported that protein kinase A (PKA) activity regulates both NF-κB transcriptional activity and Ca2+/calmodulin-dependent protein kinase II (CaMKII) activity that is able to control Ets-1 phosphorylation (19,24,38). Moreno-Fernandez et al. reported that cyclic AMP (cAMP) is transferred from regulatory T-cells to HIV-1 infected CD4+ T-cells through the connexin 43-gap junction (26). PKA activation by cAMP participates in HIV-1 suppression.

In the present study, we demonstrated that allo-antigen stimulated CD8+ T-cells are able to suppress both NF-κB and Ets-1 DNA binding activities in autologous CD4+ T-cells. The phosphorylated PKAc, Akt, and p38 MAPK were not affected in CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells. Allo-antigen stimulated CD8+ T-cells treated with a gap junction inhibitor showed no change in HIV-1-suppressive activity and reduction of nuclear NF-κB p65 localization. Although NF-κB p65 (Ser276) in CD4+ T-cells was phosphorylated in CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells, it was not transported from the cytoplasm to the nucleus. These findings indicate that allo-antigen stimulated CD8+ T-cells can suppress the transcriptional activity of both NF-κB and Ets-1, and inhibit the nuclear localization of phosphorylated NF-κB p65 (Ser276) in CD4+ T-cells.

Materials and Methods

Isolation of PBMC

This study was approved by the ethics committee in Kitasato University of Allied Health Sciences (2009-011). Informed consent was obtained from three healthy donors. PBMC were isolated by gradient centrifugation with Ficoll-Hypaque (Lymphoprep™; AXIS-SHIELD PoC, Oslo, Norway), and then stimulated overnight with 1% phytohemagglutinin-P (PHA-P’ Sigma-Aldrich, St. Louis, MO). The PBMC were then cultured in RPMI-1640 medium (Sigma-Aldrich) containing 10 U/mL recombinant human interleukin-2 (rhIL-2), 10% heat-inactivated fetal bovine serum (FBS; HyClone Laboratories, Inc., South Logan, UT), 100 U/mL penicillin, and 100 μg/mL streptomycin.

Induction of allo-antigen stimulated CD8+ T-cells

PBMC isolated from healthy donors were co-cultured with Raji cells (a human B-cell line) that had been treated with 0.05 mg/mL mitomycin C (MMC; Sigma-Aldrich) in RPMI-1640 with 10% heat-inactivated FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin. Stimulation with MMC-treated Raji was performed every week. Four weeks later, CD8+ T-cells were separated from the cell culture by magnetic activating cell sorting (MACS; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). For flow-cytometric analysis, isolated CD8+ T-cells were stained using a combination of two fluorescence-conjugated monoclonal antibodies: CD3 (fluorescein isothiocyanate, FITC) and CD8 (phycoerythrin, PE; Becton Dickinson, Franklin Lakes, NJ). The stained cells were analyzed with an EPICS XL flow cytometer and EXPO 32™ software (Beckman Coulter, Miami, FL). Allo-antigen stimulated CD8+ T-cells established from healthy donors were designated NR8-, MR8-, and TR8-CD8+ T-cells.

CD4+ and CD8+ T-cell enrichment

CD4+ and CD8+ T-cell-enriched fractions were obtained by MACS separation from PHA-stimulated PBMCs originating from the same donor as that used for allo-antigen stimulated CD8+ T-cell induction. After separation, the enriched CD4+ T-cells were cultured with autologous enriched CD8+ T-cells and allo-antigen stimulated CD8+ T-cells at a ratio of 1:3. After 1 day and 4 days of culture, CD4+ T-cells were enriched for preparation of nuclear and cytoplasmic extracts.

Preparation of nuclear and cytoplasmic extracts from CD4+ T-cells

Nuclear and cytoplasmic extracts were prepared from CD4+ T-cells using a Nuclear/Cytosol Fractionation Kit (BioVision, Inc., Mountain View, CA). The protein concentration of nuclear extracts was measured by Bradford assay (Bio-Rad Laboratories, Inc., Hercules, CA). The protein concentration in the cytoplasmic extracts was measured using a 2D-Quant kit (GE Healthcare, Little Chalfont, United Kingdom).

Electrophoresis mobility shift assay

Electrophoresis mobility shift assay (EMSA) was performed using nuclear extracts from CD4+ T-cells; double-stranded DNA oligomers were labeled with [α-32P]-dNTP with a Klenow Fragment and Random Primer DNA Labeling Kit v2.0 (Takara Bio, Inc., Shiga, Japan). Table 1 shows the sequences of the double-stranded DNA oligomers used. For blocking of nonspecific DNA-protein binding, 1 μg of nuclear extract was incubated in reaction mixture including 20 mM HEPES-KOH (pH 7.9), 50 mM KCl, 5% glycerol, 1 mM EDTA (pH 8.0), 10 mM DTT, BSA (10 mg/mL), and poly dI-dC (1 mg/mL) for 15 min on ice. After incubation, [α-32P]-labeled DNA oligomers and/or cold-competitors were added to the reaction mixture for 20 min on ice. The reaction mixture was then loaded on a 5% polyacrylamide gel and electrophoresed in 0.5× TBE buffer containing 45 mM Tris, 45 mM boric acid, and 25 mM EDTA at 150 V at 4°C. The gel was dried, and DNA-protein complexes were detected by autoradiography.

Table 1.

Sequence of Electrophoresis Mobility Shift Assay Probes

NF-κB consensus 5′-AAA AGT TGA TTT TAC TTT CCC AGG C-3′
  5′-AAA GCC TGG GAA AGT CCC CTC AAC T-3′
NF-κB LTR 5′-ACA AGG GAC TTT CCG CTG GGG ACT TTC CA-3′
  5′-CCC TGG AAA GTC CCC AGC GGA AAG TCC CT-3′
Ets consensus 5′-AAA GGG CTG CTT GAG GAA GTA TAA GAA T-3′
  5′-AAA ATT CTT ATA CTT CCT CAA GCA GCC C-3′
NFAT-1 LTR 5′-CAG AGA AGG TAG AAG AGG CCA ATG AAG GAG AGA ACA A-3′
  5′-CTG TTG TTC TCT CCT TCA TTG GCC TCT TCT ACC TTC T-3′
TCF-1 LTR 5′-GGA GTA CTA CAA GGA CTG CT-3′
  5′-TGT CAG CAG TCC TTG TAG TAC-3′
Open in a new tab

Western blotting

Nuclear and cytoplasmic extracts from CD4+ T-cells were fractionated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). Western analysis was performed using the following-primary antibodies: anti-PKA-C rabbit monoclonal antibody, anti-PKA-C phospho-Thr197 rabbit monoclonal antibody, anti-NF-κB p65 mouse monoclonal antibody, anti-NF-κB p65 phospho-Ser276 rabbit polyclonal antibody, anti-Akt rabbit polyclonal antibody, anti-Akt phospho-Ser473 rabbit monoclonal antibody, anti-p38 MAPK rabbit polyclonal antibody, anti-p38 MAPK phospho-Thr180/Tyr182 rabbit monoclonal antibody, anti-histone H3 mouse monoclonal antibody (Cell Signaling Technology Japan, K.K., Tokyo, Japan), anti-Ets-1 mouse monoclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), anti-GAPDH mouse monoclonal antibody, and anti-beta actin mouse monoclonal antibody (Abcam, Cambridge, United Kingdom). Each protein was detected using appropriate secondary antibodies: horseradish peroxidase (HRP) conjugated donkey anti-rabbit IgG polyclonal antibody (BioLegend, San Diego, CA), and HRP conjugated goat anti-mouse IgG (American Qualex, Inc., San Clemente, CA), and visualized on X-ray film (FujiFilm Corporation, Tokyo, Japan) after incubation with a chemiluminescent substrate (GE Healthcare Japan, Tokyo, Japan).

In vitro HIV-1 infection of CD4+ T-cells

HIV-1 used for in vitro infection was a filtered culture supernatant of MOLT4/LAI C-3 cells (11). For HIV-1 infection in vitro, CD4+ T-cells isolated from HIV-1 uninfected healthy donors were spinoculated with culture supernatants containing HIV-1 at a multiplicity of infection of 0.03 to 0.1 at room temperature for 1.5 h, extensively washed, and cultured in a medium containing recombinant human IL-2 at a concentration of 105 cells/200 μL in a 96-well round-bottom plate.

CD8+ T-cell treatment with a gap junction inhibitor

CD8+ T-cells were treated with connexin 43 mimetic peptide GAP 27, a gap junction inhibitor (100 μm; Sigma-Aldrich), for 2 h before co-culture with autologous CD4+ T-cells. Then, CD8+ T-cells were extensively washed, and co-cultured with HIV-1 infected CD4+ T-cells. After 4 days of incubation, the concentration of HIV-1 p24 antigen in the culture supernatants was measured using an enzyme-linked immunosorbent assay (ELISA; ELISA kits were kindly provided by Dr. Y. Tanaka, University of the Ryukyus. Japan).

Flow-cytometric analysis

PHA-treated CD8+ T-cells and established allo-antigen stimulated CD8+ T-cells were stained with the following fluorescent conjugated monoclonal antibodies: CD8 (FITC), VCAM-1 (PE), Fas-L (PE), BTLA (PE), 2B4 (PerCP/Cy5.5), PD-1 (PerCP/Cy5.5), Tim-3 (PE/Cy7), CTLA-4 (APC), and ICAM-1 (APC) (BioLegend). The stained cells were analyzed by a MACSQuant flow cytometer (Miltenyi Biotec).

Statistics

Statistical significance was analyzed using the Mann–Whitney U-test. Values were considered statistically significant when p<0.05.

Results

1. Suppression of HIV-1 replication and DNA-binding activity of transcriptional factors associated with HIV-1 replication by allo-antigen stimulated CD8+ T-cells

To study the mechanism of HIV-1 suppression by CD8+ T-cells, we investigated whether allo-antigen stimulated CD8+ T-cells established from healthy donors were able to suppress HIV-1 replication. Allo-antigen stimulated CD8+ T-cells efficiently suppressed HIV-1 replication from HIV-1 infected CD4+ T-cells, whereas no such suppressive activity was demonstrated by PHA-treated CD8+ T-cells (PHA8; Fig. 1A). To evaluate the influence of CD4+ T-cell death in the HIV-1-suppressive activity of allo-antigen stimulated CD8+ T-cells, we also examined whether uninfected CD4+ T-cells were killed by PHA8 and allo-antigen stimulated CD8+ T-cells. Neither cell death nor cleaved caspase-3 was evident in uninfected CD4+ T-cells cultured with both types of stimulated CD8+ T-cells (Supplementary Fig. S1A and B; Supplementary Data are available online at www.liebertpub.com/vim). We did not observe cell death in uninfected CD4+ T-cells cultured with culture supernatants of PHA8 and allo-antigen stimulated CD8+ T-cells (Supplementary Fig. S1C). To investigate the potential suppressive mechanism of allo-antigen stimulated CD8+ T-cells, we investigated their influence on the DNA-binding activity of transcriptional factors mainly involved in HIV-1 pathogenesis/replication in uninfected CD4+ T-cells cultured with autologous PHA8 and allo-antigen stimulated CD8+ T-cells. Using EMSA, we examined the DNA-binding activity of NF-κB, Ets-1, TCF-1, and NFAT-1. The reduction of NF-κB and Ets-1 DNA-binding activity was observed in uninfected CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells, whereas the NF-κB and Ets-1 DNA-binding activity was not affected in uninfected CD4+ T-cells cultured with PHA8 (Fig. 1B). In contrast to NF-κB or Ets-1 DNA-binding activity, neither NFAT-1 nor TCF-1 was affected in uninfected CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells (Fig. 1B). These results indicated that allo-antigen stimulated CD8+ T-cells induced HIV-1 suppression and the reduction of NF-κB and Ets-1 DNA-binding activity in autologous CD4+ T-cells.

FIG. 1.

FIG. 1.

Open in a new tab

Suppression of human immunodeficiency virus type 1 (HIV-1) replication and transcriptional activity by allo-antigen stimulated CD8+ T-cells. (A) HIV-1 infected CD4+ T-cells were cultured with autologous PHA-treated CD8+ T-cells (PHA8) and allo-antigen stimulated CD8+ T-cells (MR8) as described in Materials and Methods. The concentration of HIV-1 p24 antigens in the culture supernatants was measured by enzyme-linked immunosorbant assay (ELISA) 4 days after infection. The results indicate the average±standard deviation (SD) of triplicate wells. (B) Uninfected CD4+ T-cells were cultured with autologous PHA8 and MR8 as described in Materials and Methods. After 1 day and 4 days of incubation, nuclear extracts isolated from autologous CD4+ T-cells were incubated with 32P-labeled DNA probes corresponding to the NF-κB consensus, NF-κB LTR, Ets-1 consensus, NFAT-1 LTR, and TCF-1 LTR respectively. The data for one of three independent experiments are shown.

2. Nuclear localization of NF-κB p65 and Ets-1 in CD4+ T-cells

To investigate the cellular localization of NF-κB p65 and Ets-1, we extracted the nuclear and cytoplasmic fraction from uninfected CD4+ T-cells cultured with either PHA8 or allo-antigen stimulated CD8+ T-cells, and carried out Western blotting analysis. After 1 day and 4 days of incubation, nuclear localization of both NF-κB p65 and Ets-1 was significantly reduced in uninfected CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells (Fig. 2A–C). In contrast, there was no reduction of nuclear localization of either NF-κB or Ets-1 in uninfected CD4+ T-cells cultured with PHA8 (Fig. 2A–C). There was no evident reduction of nuclear NF-κB and Ets-1 localization in uninfected CD4+ T-cells cultured with culture supernatants of PHA8 and allo-antigen stimulated CD8+ T-cells (Supplementary Fig. 1D). We also examined the nuclear localization of NF-κB p65 in uninfected CD4+ T-cells at early stages of culture with PHA8 and allo-antigen stimulated CD8+ T-cells. After 2 h of culture, there was no evident reduction of NF-κB p65 nuclear localization in uninfected CD4+ T-cells in the presence of either type of stimulated CD8+ T-cells (Supplementary Fig. S2A and B). These results indicated that allo-antigen stimulated CD8+ T-cells inhibited the nuclear translocation of both NF-κB p65 and Ets-1 in autologous CD4+ T-cells.

FIG. 2.

FIG. 2.

Open in a new tab

Localization of NF-κB or Ets-1 in uninfected CD4+ T-cells. (A) NF-κB p65 and Ets-1 localization in uninfected CD4+ T-cells was analyzed by Western blotting. Nuclear (Nuc) and cytoplasmic (Cyto) extracts were isolated from uninfected CD4+ T-cells cultured with PHA8 and allo-antigen stimulated CD8+ T-cells (NR8) as described in Materials and Methods. (B) Nuclear localization of NF-κB p65 in uninfected CD4+ T-cells was calculated relative to the medium as a control (100%). (C) Nuclear localization of Ets-1 in uninfected CD4+ T-cells was calculated relative to the medium as a control (100%). An aliquot of nuclear and cytoplasmic extract was loaded on each lane for Western blotting. As a loading control, histone H3 or β-actin was used in the nuclear fraction or cytoplasmic fraction. Western blotting analysis was confirmed by three independent experiments. *p<0.05; **p<0.01.

3. Participation of PKA, Akt, and p38 MAPK in the reduction of NF-κB and Ets-1 DNA-binding activities

Protein kinase A (PKA) activity regulates nuclear localization and NF-κB transcriptional activity. Ets-1 is also phosphorylated by Ca2+/calmodulin-dependent kinase II (CaMKII) through PKA. To investigate the participation of PKA in the HIV-1-suppressive activity by allo-antigen stimulated CD8+ T-cells, we carried out Western blotting analysis of the PKA catalytic subunit (PKAc) and phosphorylated PKAc (Thr197) in uninfected CD4+ T-cells cultured with PHA8 and allo-antigen stimulated CD8+ T-cells. Neither PHA8 nor allo-antigen stimulated CD8+ T-cells affected the amount of PKAc in uninfected CD4+ T-cells (Fig. 3A and B). We then assessed the phosphorylated PKAc (Thr197) in uninfected CD4+ T-cells, as PKA activity is regulated by PKAc phosphorylation (Thr197). However, phosphorylated PKAc (Thr197) was not affected in uninfected CD4+ T-cells cultured with PHA8 and allo-antigen stimulated CD8+ T-cells (Fig. 3A and C). We also examined the phosphorylated PKAc (Thr197) in uninfected CD4+ T-cells at early stages of culture with PHA8 and allo-antigen stimulated CD8+ T-cells. There was no evident reduction of phosphorylated PKAc (Thr197) in uninfected CD4+ T-cells after 2 h of culture with allo-antigen stimulated CD8+ T-cells (Supplementary Fig. S2C and D). Akt, also known as protein kinase B (PKB), and p38 mitogen-activated protein kinase (MAPK) are also known to regulate NF-κB signaling via activation of the IKK complex and induction of IκB degradation. To study the participation of Akt and p38 MAPK in HIV-1-suppressive activity, we further examined the phosphorylation of both Akt and p38 MAPK in uninfected CD4+ T-cells cultured with PHA8 and allo-antigen stimulated CD8+ T-cells. The amounts of phosphorylated Akt and p38 MAPK were not significantly affected in uninfected CD4+ T-cells under either of these culture conditions (Fig. 3D–F). Similarly, the amounts of unphosphorylated Akt and p38 MAPK were unaffected (data not shown). These results suggested that the reduction of NF-κB p65 and Ets-1 activities in uninfected CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells might not be due to PKAc, Akt, and p38 MAPK activation.

FIG. 3.

FIG. 3.

Open in a new tab

Analysis of PKAc, Akt, and p38 MAPK activity in the cytoplasm of uninfected CD4+ T-cells cultured with CD8+ T-cells. (A) PKAc and phosphorylated PKAc (Thr197) in uninfected CD4+ T-cells were analyzed by Western blotting. Cytoplasmic extracts were isolated from autologous uninfected CD4+ T-cells cultured with PHA8 and allo-antigen stimulated CD8+ T-cells (NR8) as described in Materials and Methods. (B) The relative amount of PKAc in uninfected CD4+ T-cells was calculated considering the medium as a control (100%). (C) The relative amount of phosphorylated PKAc (Thr197) in uninfected CD4+ T-cells was calculated considering the medium as a control (100%). (D) Akt and phosphorylated Akt (Ser473), p38 MAPK and phosphorylated p38 MAPK (Thr180/Tyr182) in uninfected CD4+ T-cells were analyzed by Western blotting. Cytoplasmic extracts were isolated from uninfected CD4+ T-cells cultured with PHA8 and allo-antigen stimulated CD8+ T-cells (TR8) as described in Materials and Methods. (E) The relative amount of phosphorylated Akt (Ser473) in uninfected CD4+ T-cells was calculated considering the medium as a control (100%). (F) The relative amount of phosphorylated p38 MAPK (Thr180/Tyr182) in uninfected CD4+ T-cells was calculated considering the medium as a control (100%). An aliquot of cytoplasmic extract was loaded on each lane, and β-actin and GAPDH were used as a loading control. Western blotting analysis was confirmed by four independent experiments. n.s. not significant.

4. Effects of the cAMP influx from allo-antigen stimulated CD8+ T-cells to CD4+ T-cells on HIV-1 replication and DNA-binding activity

Cyclic AMP (cAMP) can flow from cell to cell gap junctions, and activate PKA. To investigate the HIV-1 suppressive effect of cAMP influx, we examined whether HIV-1 replication was inhibited by transfer of cAMP through gap junctions from allo-antigen stimulated CD8+ T-cells to autologous HIV-1 infected CD4+ T-cells. To inhibit cAMP influx, PHA8 and allo-antigen stimulated CD8+ T-cells were treated with a connexin 43 gap junction inhibitor (GAP 27), as described in Materials and Methods. Although allo-antigen stimulated CD8+ T-cells suppressed HIV-1 replication in autologous HIV-1 infected CD4+ T-cells, GAP 27 treatment of allo-antigen stimulated CD8+ T-cells did not affect abrogation of the HIV-1 suppressive activity with allo-antigen stimulated CD8+ T-cells (Fig. 4A). At the same time, we also examined the nuclear localization and DNA-binding activity of NF-κB in uninfected CD4+ T-cells cultured with GAP 27-treated PHA8 and allo-antigen stimulated CD8+ T-cells. We also observed the reduction of NF-κB nuclear localization and DNA-binding activity in uninfected CD4+ T-cells cultured with GAP 27-treated allo-antigen stimulated CD8+ T-cells (Fig. 4B and C). These results suggested that HIV-1 suppression by allo-antigen stimulated CD8+ T-cells was not related to molecules involved in the passage of cAMP through connexin 43 gap junctions.

FIG. 4.

FIG. 4.

Open in a new tab

Participation of gap junctions in HIV-1 suppression by allo-antigen stimulated CD8+ T-cells. (A) PHA-treated and allo-antigen stimulated CD8+ T-cells (TR8) were treated with GAP 27 as a gap junction inhibitor 2 h before co-culture, as described in Materials and Methods. Then GAP 27-treated and -untreated CD8+ T-cells were cultured with HIV-1 infected CD4+ T-cells. The concentration of HIV-1 p24 antigens in the culture supernatants was measured by ELISA 4 days after infection. The results indicate the average±SD of triplicate wells. (B) Nuclear localization of NF-κB p65 in uninfected CD4+ T-cells cultured with GAP 27-treated or -untreated PHA8 and TR8 was calculated relative to the medium as a control (100%). (C) Uninfected CD4+ T-cells were cultured with GAP 27-treated PHA8 and TR8. After 1 day of incubation, the nuclear extract of uninfected CD4+ T-cells was incubated with the 32P-labeled DNA probe of NF-κB LTR. The data for one of two independent experiments are shown.

5. Cellular localization of phosphorylated NF-κB p65 (Ser276) in CD4+ T-cells

As described above, NF-κB p65 in uninfected CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells localized more in the cytoplasm than in the nucleus (Fig. 2A). NF-κB nuclear translocation occurs after IκBα, which masks nuclear localization signal of NF-κB p65, is degraded by proteasomes. Phosphorylation of NF-κB p65 by a number of kinases enhances NF-κB transcriptional activity and nuclear localization. To clarify the state of nuclear phosphorylated NF-κB p65, we investigated whether NF-κB p65 in the cytoplasm and nucleus of uninfected CD4+ T-cells cultured with PHA8 and allo-antigen stimulated CD8+ T-cells was phosphorylated at serine residues 276 and 536. Phosphorylated NF-κB p65 (Ser276) in the cytoplasm was observed only in uninfected CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells, whereas it was not detected in uninfected CD4+ T-cells cultured with PHA8 (Fig. 5A). We observed less phosphorylated NF-κB p65 (Ser276) in the nuclei of CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells than in those cultured with PHA8 for 1 day. After 4 days of culture, phosphorylated NF-κB p65 (Ser276) was not clearly detectable in the nuclei of uninfected CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells (Fig. 5A and B), whereas it was transported from the cytoplasm to the nucleus in uninfected CD4+ T-cells cultured with PHA8 (Fig. 5A and B). Phosphorylated NF-κB p65 (Ser276) was only retained in the cytoplasm of uninfected CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells (Fig. 5A and B), but the total amounts of phosphorylated NF-κB p65 (Ser276) and NF-κB p65 in uninfected CD4+ T-cells did not differ, irrespective of culture with PHA8 and allo-antigen stimulated CD8+ T-cells (Fig. 5A and C). In contrast, there was no difference in the amount of cytoplasmic phosphorylated NF-κB p65 (Ser536) in uninfected CD4+T-cells, irrespective of culture with PHA8 and allo-antigen stimulated CD8+ T-cells (Supplementary Fig. S3). These results indicated that although NF-κB p65 was phosphorylated in CD4+ T-cells cultured with PHA8 and allo-antigen stimulated CD8+ T-cells, nuclear transport of a proportion of phosphorylated NF-κB p65 (Ser276) was inhibited by an unknown HIV-1 suppressive mechanism potentially related to HIV-1 pathogenesis/replication by allo-antigen stimulated CD8+ T-cells.

FIG. 5.

FIG. 5.

Open in a new tab

Analysis of phosphorylated NF-κB p65 Ser276 in uninfected CD4+ T-cells. (A) Phosphorylated NF-κB p65 (Ser276) in uninfected CD4+ T-cells was analyzed by Western blotting. Nuclear (Nuc) and cytoplasmic (Cyto) extracts were isolated from uninfected CD4+ T-cells cultured with PHA8 and allo-antigen stimulated CD8+ T-cells (NR8) as described in Materials and Methods. (B) The amount of nuclear phosphorylated NF-κB p65 (Ser276) was expressed as a ratio of the amount present in the nuclear and cytoplasmic phosphorylated NF-κB p65 (Ser276). The percentage of nuclear phosphorylated NF-κB p65 (Ser276) was expressed relative to that in the medium as a control (100%). (C) The relative amounts of nuclear and cytoplasmic phosphorylated NF-κB p65 (Ser276) were expressed as a ratio relative to the amounts of total nuclear and cytoplasmic NF-κB p65. The percentages of nuclear and cytoplasmic phosphorylated NF-κB p65 (Ser276) were expressed relative to those in the medium as a control (100%). An aliquot of nuclear and cytoplasmic extracts was loaded on each lane. Western blotting analysis was confirmed by three independent experiments. *p<0.05.

6. Flow cytometric analysis of allo-antigen stimulated CD8+ T-cells

To study the differences in HIV-1-suppressive activity between PHA8 and allo-antigen stimulated CD8+ T-cells, we compared the surface expression of costimulatory molecules, adhesion molecules, and negative regulatory molecules on CD8+ T-cells. Neither cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) nor Fas-ligand (Fas-L) was expressed on either PHA8 or allo-antigen stimulated CD8+ T-cells, whereas the expression of B and T lymphocyte attenuator (BTLA) tended to be slightly higher on the former than on the latter. Expression of vascular cell adhesion molecule 1 (VCAM-1) was slightly higher on allo-antigen stimulated CD8+ T-cells than PHA8, whereas that of intercellular adhesion molecule 1 (ICAM-1) was significantly higher on the former. Allo-antigen stimulated CD8+ T-cells showed higher expression of 2B4, programmed death-1 (PD-1), and T-cell immunoglobulin domain and mucin domain-3 (Tim-3; Fig. 6 and Table 2). These results indicated that CD8+ T-cells stimulated with allo-antigen might be more exhausted than those stimulated with PHA, but that higher expression of ICAM-1 on allo-antigen stimulated CD8+ T-cells might strengthen cell-to-cell contact between autologous CD4+ T-cells and allo-antigen stimulated CD8+ T-cells.

FIG. 6.

FIG. 6.

Open in a new tab

Characterization of allo-antigen stimulated CD8+ T-cells. Allo-antigen stimulated CD8+ T-cells (black line) and PHA-treated CD8+ T-cells (gray line) derived from three healthy donors were characterized by flow-cytometric analysis using immunofluorescent antibodies staining for CD8, CTLA-4, BTLA, Fas-L, VCAM-1, ICAM-1, 2B4, PD-1, and Tim-3. The data for one of five independent experiments are shown.

Table 2.

Characterization of PHA-Treated and Allo-Antigen Stimulated CD8+ T-Cells

  CTLA-4 BTLA Fas-L VCAM-1 ICAM-1 2B4 PD-1 Tim-3
PHA8 0.05±0.03 39.06±16.06 1.03±0.73 4.28±2.79 21.05±13.05 15.81±8.34 11.32±7.79 19.80±11.75
Allo8 0.30±0.24 28.82±5.39 1.08±1.04 12.16±15.09 65.04±14.54** 31.61±18.12 17.93±10.46 41.58±22.69
Open in a new tab

The results indicate the average±SD of five independent experiments. **p<0.01.

PHA8, PHA-treated CD8+ T-cells; Allo8, allo-antigen stimulated CD8+ T-cells.

Discussion

In the present study, we showed that allo-antigen stimulated CD8+ T-cells established from uninfected healthy donors induced a reduction of DNA binding activity of NF-κB and Ets-1 in uninfected CD4+ T-cells in vitro (Fig. 1). Nuclear localization of NF-κB p65 and Ets-1 was reduced in uninfected CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells (Fig. 2). We confirmed that the HIV-1-suppressive activity of allo-antigen stimulated CD8+ T-cells was caused by reduction of NF-κB p65 and Ets-1 in the nucleus. Levy et al. reported that CD8+ CAF produced by CD8+ T-cells of asymptomatic carriers is able to suppress HIV-1 replication at the transcriptional level without causing cell killing (22). Le Borgne et al. previously reported that Epstein-Barr virus-specific CTLs from an HIV-seronegative donor suppressed HIV-1 replication (17). Moreover, previous reports have shown that HIV-1-irrelevant allo-antigen stimulated CD8+ T-cells established from healthy donors are able to suppress HIV-1 viral replication at the late stage (16,21). We demonstrated that cell viability and the reduction of nuclear NF-κB p65 and Ets-1 localization in CD4+ T-cells were not influenced by culture with culture supernatants of PHA-treated and allo-antigen stimulated CD8+ T-cells (Supplementary Fig. S1). Our results are in accord with these reports, and we were able to identify the transcriptional factors, NF-κB and Ets-1, as key players in HIV-1 suppression mediated by allo-antigen stimulated CD8+ T-cells. Activated CD8+ T-cells established by allo-antigen stimulation might have functions for NF-κB- and Ets-1-mediated reduction of both DNA-binding activity and nuclear localization.

Akt and p38 MAPK regulate NF-κB signaling via the activation of IKK complex and the induction of IκB degradation (23,36,40). Moreover, PKA activity regulates NF-κB transcriptional activity through NF-κB p65 (Ser276) phosphorylation (38). NF-κB p65 (Ser276) phosphorylation upregulates NF-κB transcriptional activity through various effects including recruitment of cAMP response element binding protein (CREB) binding protein (CBP)/p300, which is a transcriptional co-activator (9,51,52). A previous study has shown that cAMP negatively regulates HIV-1 enhancer activity and virus production. CREB protein activated by cAMP-dependent PKA activity competes with phosphorylated NF-κB and Ets-1 proteins for limiting amounts of CBP/p300 (2). Therefore, we focused on PKA activity because PKA is able to control both NF-κB p65 and Ets-1 transcriptional activity. In the present study, however, we found no differences of phosphorylated PKAc (Thr197), Akt (Ser473), and p38 MAPK (Thr180/Tyr182) in uninfected CD4+ T-cells cultured with PHA8 and allo-antigen stimulated CD8+ T-cells (Fig. 3). Previously, Moreno-Fernandez et al. reported that regulatory T-cells also control HIV-1 replication in autologous CD4+ T-cells by cAMP-dependent PKA activation through gap junctions (26). We examined whether allo-antigen stimulated CD8+ T-cells have the HIV-1 suppressive mechanism that is similar to regulatory T-cells. However, treatment of allo-antigen stimulated CD8+ T-cells with GAP 27 did not affect HIV-1 replication in autologous CD4+ T-cells (Fig. 4). We considered that the reduction of NF-κB p65 and Ets-1 nuclear localization might not be regulated by the difference of PKAc in uninfected CD4+ T-cells cultured with PHA8 and allo-antigen stimulated CD8+ T-cells.

Interestingly, the phosphorylated NF-κB p65 (Ser276) was only retained in the cytoplasm of uninfected CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells (Fig. 5). The A kinase interacting protein 1 (AKIP1) binds to NF-κB p65 and regulates its transcriptional activity through phosphorylation at serine residue 276 by PKAc (14). Nuclear accumulation of NF-κB p65 can be delayed by replacing serine residue 276 with a phosphomimetic. Although the contribution of AKIP1 is unknown in our study, AKIP activity might play a role in the HIV-1-suppressive mechanism in CD4+ T-cells cultured with allo-antigen stimulated CD8+ T-cells.

It has been reported that NF-κB signaling is negatively regulated by inhibition of DNA-binding function, IKK activity, and IκB degradation. Protein inhibitor of activated STAT1 (PIAS1) directly interacts with NF-κB p65 and prevents it from binding to DNA (20). Another member of the PIAS family, PIASy, also negatively regulates both STAT1 and NF-κB signaling by cooperating with PIAS1 (37). Fas-associated Factor-1 (FAF-1) inhibits the nuclear transport of NF-κB p65. FAF-1 disrupts IKK complex formation through physical interaction with the leucine-zipper domain of IKKβ, and attenuates IKKγ recruitment to IKKβ. As a result, FAF-1 suppresses NF-κB activation by inhibiting the nuclear localization of NF-κB p65 (31,32). Another study has shown that caveolin 1 (Cav-1), the scaffold protein of a specific membrane lipid raft known as a caveola, is also expressed in T lineage cells, dendritic cells, and monocytes/macrophages (39,46). Cav-1 suppresses HIV-1 replication and decreases the translocation of NF-κB p65 to the nucleus in Cav-1-overexpressing cell lines and macrophages (46). A20 is also one of the major negative regulators of NF-κB signaling, mediating the removal of K63-polyubiquitin chains from receptor interacting protein 1 (RIP1), and catalyzing RIP1 K48-polyubiquitination, thus allowing RIP1 to be degraded by proteasomes (47). Moreover, TAXBP1, which was first identified as a protein that interacts with HTLV Tax protein, facilitates the interaction of A20 with RIP1 (35). A20 binding inhibitors of NF-κB (ABIN) interacts with A20 and also negatively regulates NF-κB signaling (41,42). It has also been reported another member the ABIN family, ABIN-2, markedly reduces hepatectomy-induced NF-κB p65 nuclear localization in hepatocytes of ABIN-2 transgenic mice, relative that that in wild-type mice (18). Various molecules expressed on allo-antigen stimulated CD8+ T-cells are likely to influence signal transduction through PIAS1, FAF-1, Cav-1, A20, ABINs, TAXBP1, or AKIP1 in CD4+ T-cells expressing receptor molecule(s). The nature of these molecules remains to be clarified.

In investigating whether some molecules on CD8+ T-cells are associated with suppression of HIV-1 replication, we found marked differences of 2B4, Tim-3, and ICAM-1 expression on allo-antigen stimulated CD8+ T-cells (Fig. 6 and Table 2). Yamamoto et al. reported that the negative regulatory molecules PD-1, CD160, and 2B4 are more highly expressed on HIV-specific CD8+ T-cells before antiretroviral therapy (49). These molecules are highly expressed on the surface of exhausted CD8+ T-cells. Our established allo-antigen stimulated CD8+ T-cells showed high expression of 2B4 and Tim-3, and slight expression of PD-1. This might suggest that CD8+ T-cells stimulated with allo-antigen might be more exhausted than those stimulated with PHA. Diaz et al. have reported that VCAM-1 expression on CD8+ T-cells correlates with enhanced anti-HIV-1 suppression activity (8). They showed that VCAM-1+CD8+ T-cells produce an anti-HIV soluble factor, such as CAF, but not VCAM-1, as anti-VCAM-1 antibody had no effect on the noncytotoxic anti-HIV response of CD8+ cells. Our established allo-antigen stimulated CD8+ T-cells tended to show slightly higher cell surface expression of VCAM-1 than CD8+ T-cells stimulated with PHA. However, we also demonstrated variation of VCAM-1 expression on allo-antigen stimulated CD8+ T-cells. Although VCAM-1 might play a role in the HIV-1-suppressive activity of CD8+ T-cells, it may not be the main player in the HIV-1-suppressive activity observed in the present system. Although our allo-antigen stimulated CD8+ T-cells showed high expression of ICAM-1, it is not clear whether ICAM-1 possesses direct HIV-1-suppressive activity. ICAM-1 may strengthen the response of CD4+ T-cells to contact with allo-antigen stimulated CD8+ T-cells.

In this study, we have identified the key transcriptional factors, NF-κB p65 and Ets-1, related to HIV-1 suppression at the transcriptional level by allo-antigen stimulated CD8+ T-cells. Furthermore, this suppressive mechanism by allo-antigen stimulated CD8+ T-cells inhibits the nuclear transport of NF-κB p65, including phosphorylated NF-κB p65. In a future study, we intend to identify the factor(s) or mechanism(s) inhibiting the nuclear transport of phosphorylated NF-κB p65 (Ser276). If this HIV-1-suppressive mechanism(s) by allo-antigen stimulated CD8+ T-cells can be clarified, it will contribute to the development of therapeutic agents for HIV-1 and a new strategy for therapeutic vaccines.

Supplementary Material

Supplemental data
Supp_Fig1.pdf (92.2KB, pdf)
Supplemental data
Supp_Fig2.pdf (92KB, pdf)
Supplemental data
Supp_Fig3.pdf (57.3KB, pdf)

Acknowledgments

We thank Dr. Mari Kannagi (Tokyo Medical and Dental University, Japan) for kindly providing MOLT4/LAI C-3 cells, and Dr. Yuetsu Tanaka (University of the Ryukyus, Japan) for kindly providing HIV-1 p24 ELISA kit. This study was supported by the Graduate School of Medical Sciences, Kitasato University (Integrative Research Program, 2008–2009, 2013), by Kitasato University Research Grant for Young Researchers (Grant-in Aid 2008), and the Kanagawa Nanbyou Study Foundation (Grant-in Aid 2007).

Author Disclosure Statement

No competing financial interests exist.

References

  • 1.Baier M, Werner A, Bannert N, Metzner K, and Kurth R. HIV suppression by interleukin-16. Nature 1995;378:563. [DOI] [PubMed] [Google Scholar]
  • 2.Banas B, Eberle J, Schlondorff D, and Luckow B. Modulation of HIV-1 enhancer activity and virus production by cAMP. FEBS Lett 2001;509:207–212 [DOI] [PubMed] [Google Scholar]
  • 3.Barker TD, Weissman D, Daucher JA, Roche KM, and Fauci AS. Identification of multiple and distinct CD8+ T cell suppressor activities: dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation. J Immunol 1996;156:4476–4483 [PubMed] [Google Scholar]
  • 4.Borrow P, Lewicki H, Hahn BH, Shaw GM, and Oldstone MB. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103–6110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Center DM, Kornfeld H, Ryan TC, and Cruikshank WW. Interleukin 16: implications for CD4 functions and HIV-1 progression. Immunol Today 2000;21:273–280 [DOI] [PubMed] [Google Scholar]
  • 6.Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, and Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811–1815 [DOI] [PubMed] [Google Scholar]
  • 7.Collins KL, Chen BK, Kalams SA, Walker BD, and Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998;391:397–401 [DOI] [PubMed] [Google Scholar]
  • 8.Diaz LS, Foster H, Stone MR, Fujimura S, Relman DA, and Levy JA. VCAM-1 expression on CD8+ cells correlates with enhanced anti-HIV suppressing activity. J Immunol 2005;174:1574–1579 [DOI] [PubMed] [Google Scholar]
  • 9.Dong J, Jimi E, Zhong H, Hayden MS, and Ghosh S. Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms. Genes Dev 2008;22:1159–1173 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ferbas J, Kaplan AH, Hausner MA, Hultin LE, Matud JL, Liu Z, Panicali DL, Nerng-Ho H, Detels R, and Giorgi JV. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis 1995;172:329–339 [DOI] [PubMed] [Google Scholar]
  • 11.Harada S, Kobayashi N, Koyanagi Y, and Yamamoto N. Clonal selection of human immunodeficiency virus (HIV): serological differences in the envelope antigens of the cloned viruses and HIV prototypes (HTLV-III B, LAV, and ARV). Virology 1987;158:447–451 [DOI] [PubMed] [Google Scholar]
  • 12.Kannagi M, Chalifoux LV, Lord CI, and Letvin NL. Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. J Immunol 1988;140:2237–2242 [PubMed] [Google Scholar]
  • 13.Kannagi M, Masuda T, Hattori T, Kanoh T, Nasu K, Yamamoto N, and Harada S: Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro. J Virol 1990;64:3399–3406 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.King CC, Sastri M, Chang P, Pennypacker J, and Taylor SS. The rate of NF-κB nuclear translocation is regulated by PKA and A kinase interacting protein 1. PLoS One 2011;6:e18713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Koenig S, Fuerst TR, Wood LV, et al. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. J Immunol 1990;145:127–135 [PubMed] [Google Scholar]
  • 16.Kubo M, Nishitsuji H, Kurihara K, Hayashi T, Masuda T, and Kannagi M. Suppression of human immunodeficiency virus type 1 replication by arginine deiminase of Mycoplasma arginini. J Gen Virol 2006;87:1589–1593 [DOI] [PubMed] [Google Scholar]
  • 17.Le Borgne S, Fevrier M, Callebaut C, Lee SP, and Riviere Y. CD8(+)-cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription. J Virol 2000;74:4456–4464 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Li CC, Chou CK, Wang MH, and Tsai TF. Overexpression of ABIN-2, a negative regulator of NF-kappaB, delays liver regeneration in the ABIN-2 transgenic mice. Biochem Biophys Res Commun 2006;342:300–309 [DOI] [PubMed] [Google Scholar]
  • 19.Liu H, and Grundstrom T. Calcium regulation of GM-CSF by calmodulin-dependent kinase II phosphorylation of Ets1. Mol Biol Cell 2002;13:4497–4507 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Liu B, Yang R, Wong KA, et al. Negative regulation of NF-kappaB signaling by PIAS1. Mol Cell Biol 2005;25:1113–1123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Liu H, Ohashi T, Masuda T, Zhou X, Kubo M, and Kannagi M. Suppression of HIV-1 replication by HIV-1-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-1-infected cells in vitro. Viral Immunol 2003;16:381–393 [DOI] [PubMed] [Google Scholar]
  • 22.Mackewicz CE, Blackbourn DJ, and Levy JA. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci U S A 1995;92:2308–2312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Madrid LV, Mayo MW, Reuther JY, and Baldwin AS., Jr Akt Stimulates the transactivation potential of the RelA/p65 Subunit of NF-κB through utilization of the IkB kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 2001;276:18934–18940 [DOI] [PubMed] [Google Scholar]
  • 24.Makhinson M, Chotiner JK, Watson JB, and O'Dell TJ. Adenylyl cyclase activation modulates activity-dependent changes in synaptic strength and Ca2+/calmodulin-dependent kinase II autophosphorylation. J Neurosci 1999;19:2500–2510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.McMichael AJ, and Rowland-Jones SL. Cellular immune responses to HIV. Nature 2001;410:980–987 [DOI] [PubMed] [Google Scholar]
  • 26.Moreno-Fernandez ME, Rusie LK, and Chougnet CA. Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism. Blood 2011;117:5327–5380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833–835 [DOI] [PubMed] [Google Scholar]
  • 28.Ohashi T, Arai M, Kato H, et al. High SDF-1 expression in HIV-1 carriers does not correlate with CD8+ T-cell-mediated suppression of viral replication. Virology 1998;244:467–472 [DOI] [PubMed] [Google Scholar]
  • 29.Ohashi T, Kubo M, Kato H, Iwamoto A, Takahashi H, Fujii M, and Kannagi M. Role of class I major histocompatibility complex-restricted and -unrestricted suppression of human immunodeficiency virus type 1 replication by CD8+ T lymphocytes. J Gen Virol 1999;80 (Pt 1):209–216 [DOI] [PubMed] [Google Scholar]
  • 30.Pal R, Garzino-Demo A, Markham PD, et al. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science 1997;278:695–698 [DOI] [PubMed] [Google Scholar]
  • 31.Park MY, Jang HD, Lee SY, Lee KJ, and Kim E. Fas-associated factor-1 inhibits nuclear factor-kappaB (NF-kappaB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-kappaB. J Biol Chem 2004;279:2544–2549 [DOI] [PubMed] [Google Scholar]
  • 32.Park MY, Moon JH, Lee KS, Choi HI, Chung J, Hong HJ, and Kim E. FAF1 suppresses IkappaB kinase (IKK) activation by disrupting the IKK complex assembly. J Biol Chem 2007;282:27572–27577 [DOI] [PubMed] [Google Scholar]
  • 33.Plata F, Autran B, Martins LP, et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 1987;328:348–351 [DOI] [PubMed] [Google Scholar]
  • 34.Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999;283:857–860 [DOI] [PubMed] [Google Scholar]
  • 35.Shembade N, Harhaj NS, Liebl DJ, and Harhaj EW. Essential role for TAXBP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling. EMBO J 2007;26:3910–3922 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Slminen A, and Kaarnirata K. Insulin/IGF-1 paradox of aging: Regulation via AKT/IKK/NF-κB signaling. Cell Signal 2010;22:573–577 [DOI] [PubMed] [Google Scholar]
  • 37.Tahk S, Liu B, Chernishof V, Wong KA, Wu H, and Shuai K. Control of specificity and magnitude of NF-kappa B and STAT1-mediated gene activation through PIASy and PIAS1 cooperation. Proc Natl Acad Sci U S A 2007;104:11643–11648 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Takahashi N, Tetsuka T, Uranishi H, and Okamoto T. Inhibition of the NF-kappaB transcriptional activity by protein kinase A. Eur J Biochem 2002;269:4559–4565 [DOI] [PubMed] [Google Scholar]
  • 39.Tomassian T, Humphries LA, Liu SD, Silva O, Brooks DG, and Miceli MC. Caveolin-1 orchestrates TCR synaptic polarity, signal specificity, and function in CD8 T cells. J Immunol 2011;187:2993–3002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Vasudevan KM, Gurumurthy S, and Rangnekar VM. Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol Cell Biol 2004;24:1007–1021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Verstrepen L, Carpentier I, Verhelst K, and Beyaert R. AIBNs: A20 biding inhibitors of NF-kappa B and apoptosis signaling. Biochem Pharmacol 2009;78:105–114 [DOI] [PubMed] [Google Scholar]
  • 42.Wagner S, Carpentier I, Rogov V, et al. Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins. Oncogene 2008;27:3739–3745 [DOI] [PubMed] [Google Scholar]
  • 43.Walker BD, Chakrabarti S, Moss B, et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987;328:345–348 [DOI] [PubMed] [Google Scholar]
  • 44.Walker BD, and Plata F. Cytotoxic T lymphocytes against HIV. AIDS 1990;4:177–184 [DOI] [PubMed] [Google Scholar]
  • 45.Walker CM, Moody DJ, Stites DP, and Levy JA. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563–1566 [DOI] [PubMed] [Google Scholar]
  • 46.Wang XM, Nadeau PE, Lin S, Abbott JR, and Mergia A. Caveolin 1 inhibits HIV replication by transcriptional repression mediated through NF-κB. J Virol 2011;85:5483–5493 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wertz IE, O'Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signaling. Nature 2004;430:694–699 [DOI] [PubMed] [Google Scholar]
  • 48.Yamamoto JK, Kruzel ML, Louie H, and Georgiades JA. Inhibition of human immunodeficiency virus type 1 replication by human interferons alpha, beta and gamma. Arch Immunol Ther Exp (Warsz) 1993;41:185–191 [PubMed] [Google Scholar]
  • 49.Yamamoto T, Price DA, Casazza JP, et al. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T cell exhaustion in HIV infection. Blood 2011;117:4805–4815 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Zhang L, Yu W, He T, et al. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 2002;298:995–1000 [DOI] [PubMed] [Google Scholar]
  • 51.Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, and Ghosh S. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 1997;89:413–424 [DOI] [PubMed] [Google Scholar]
  • 52.Zhong H, Voll RE, and Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998;1:661–671 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental data
Supp_Fig1.pdf (92.2KB, pdf)
Supplemental data
Supp_Fig2.pdf (92KB, pdf)
Supplemental data
Supp_Fig3.pdf (57.3KB, pdf)

Articles from Viral Immunology are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES